Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Genetics
• Immunology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with increasing incidence and male preponderance.
• The selective vulnerability of the cortico-motoneuronal system in ALS remains incompletely understood.
• Recent advances in molecular biology and genetics prompt a re-evaluation of potential pathogenic mechanisms.

Purpose of the Study:

• To review and synthesize recent research on the pathogenic mechanisms of amyotrophic lateral sclerosis (ALS).
• To consider how identified mechanisms align with clinical observations such as increasing incidence and male predominance.

Main Methods:

• Review of recent advances in molecular biology and genetics related to familial ALS.
• Analysis of studies investigating excitotoxicity, including amino acid levels and receptor changes in ALS patients.
• Examination of research on immune-mediated mechanisms, including antibodies to L-type calcium channels and animal models.
• Consideration of other proposed mechanisms: elemental toxicity, apoptosis, and growth factor abnormalities.

Main Results:

• Mutations in the superoxide dismutase 1 (SOD1) gene suggest a role for oxidative stress in familial ALS.
• Evidence implicates excitotoxicity, supported by altered amino acid profiles and excitatory amino acid receptor changes.
• Immune-mediated mechanisms are gaining traction, evidenced by autoantibodies and immune-based motor neuron models.
• Other potential factors include elemental toxicity, programmed cell death (apoptosis), and growth factor dysregulation.

Conclusions:

• Multiple pathogenic pathways, including oxidative stress, excitotoxicity, and immune responses, are implicated in ALS.
• A comprehensive understanding of ALS pathogenesis must integrate these diverse mechanisms.
• Further research is needed to elucidate the interplay of these factors and explain disease characteristics.